Kestra Medical Company Insiders

Kestra Medical Management Team Effectiveness

The company has return on total asset (ROA) of (0.4395) % which means that it has lost $0.4395 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.264) %, meaning that it created substantial loss on money invested by shareholders. Kestra Medical's management efficiency ratios could be used to measure how well Kestra Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.36 in 2026. Return On Capital Employed is likely to drop to -0.39 in 2026. At this time, Kestra Medical's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 48.8 M in 2026, whereas Return On Tangible Assets are likely to drop (0.36) in 2026. Common Stock Shares Outstanding is likely to drop to about 39.6 M in 2026Kestra Medical Techn maintains a total of 58.35 Million outstanding shares. The majority of Kestra Medical outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Kestra Medical Technologies to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Kestra Medical Techn. Please pay attention to any change in the institutional holdings of Kestra Medical as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Kestra Medical in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Kestra Medical, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Kestra Medical Workforce Comparison

The company has Profit Margin (PM) of (1.78) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.41) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.41.

Kestra Medical Insider Trading

Kestra Medical Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Kestra Medical Techn often depends on how effective the management is. Kestra Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Kestra management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Kestra management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Kestra Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Kestra Medical Technologies. Check Kestra Medical's Beneish M Score to see the likelihood of Kestra Medical's management manipulating its earnings.

When running Kestra Medical's price analysis, check to measure Kestra Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kestra Medical is operating at the current time. Most of Kestra Medical's value examination focuses on studying past and present price action to predict the probability of Kestra Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kestra Medical's price. Additionally, you may evaluate how the addition of Kestra Medical to your portfolios can decrease your overall portfolio volatility.